Home 2025

Archives

Figure 1. Landmarks of the peripapillary intrachoroidal cavitation (PICC). LC = lamina cribrosa. BM = Bruch’s membrane (dashed red arrow). SF = scleral flange, the sclera between the dura and the pia mater. D = dura mater. PICC (red star) is in front of the subarachnoid space (yellow star). It is a suprachoroidal detachment. It is suggested to be promoted by a direct traction force (blue arrow) of the dura mater during eye movements. A tangential component of this traction force squeezes the choroid at the end of the posterior outpouching (red arrowheads). The device used is the Spectral Domain OCT Spectralis® HRA-OCT, model S3300 (Heidelberg Engineering GmbH, Heidelberg Germany). Note: Reprinted from Peripapillary Intrachoroidal Cavitation. Adèle Ehongo et al. ‘J. Clin. Med. 2023, 12, 4712’ Originally published by and used with permission from MDPI.

Understanding the link between PICC and myopic complications

Dr Adèle Ehongo discusses the pathogenesis of peripapillary intra-choroidal cavitation and its implications for myopic complications.
Figure 1. photo of a peripapillary intrachoroidal cavitation. The crescent-shaped atrophic area (red star), at the border of the optic nerve head (black star), called myopic conus, is alone in (A). It presents a circumscribed, yellow-orange lesion (white star) at its outer border in (B), corresponding to the peripapillary intrachoroidal cavitation. Note: Figures 1 and 2 are reprinted from Peripapillary Intrachoroidal Cavitation. Adèle Ehongo et al. ‘J. Clin. Med. 2023, 12, 4712’ Originally published by and used with permission from MDPI.

Spotting peripapillary intra-choroidal cavitation using OCT

Adèle Ehongo explores the potential of optical coherence tomography for diagnosing peripapillary intra-choroidal cavitation in myopic eyes.
Girl Undergoing Eye Examination

Sight loss research: Looking forward to an equitable future

Keith Valentine, Chief Executive of Fight for Sight and Vision Foundation, shares how these newly merged organisations are driving efforts in sight loss research to improve patient care.
There is time to intervene in AMD before end-stage disease occurs

Understanding age-related macular degeneration

Tunde Peto, Professor of Clinical Ophthalmology at Queen’s University Belfast, describes the symptoms, causes and treatments for age-related macular degeneration and how the prevalence of the disease could be reduced.

Follow Us

Advertisements